What's new in the management of chronic heart failure

Dr Harriette Van Spall is an associate professor in the Division of Cardiology, Department of Medicine, McMaster University, Canada.

See also

Management of chronic coronary syndromes according to the latest practice guidelines A lecture by Dr David Hasdai from Tel Aviv University, Israel, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
Acute coronary syndromes: from a chest pain to an intervention. Key practical messages from current ESC practice guidelines A lecture by Dr Christian Mueller from University Hospital of Basel, Switzerland, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
Is physical examination of the cardiovascular system still important? A lecture by Dr Andrew Elder from University of Edinburgh, United Kingdom, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
5 things every internist should know about anticoagulants Dr Siraj Mithoowani lists the most important issues related to anticoagulation.
The 3 most important recent advances in the treatment of arterial hypertension Dr Reinhold Kreutz from Charité - Universitätsmedizin Berlin, Germany, presents the 3 most important recent advances in the treatment of arterial hypertension.
Optimizing heart failure therapy in an ICD clinic Dr Aiman Alak from McMaster University joins Dr Khalid Azzam to review the role of optimal medical therapy in patients with heart failure with reduced ejection fraction (HFrEF).
The 3 most important recent advances in treating heart failure Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, shares her views on the 3 most important recent advances in treating heart failure.
Heart failure treatment: A decade of progress Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, puts in context some of the most impactful heart failure clinical trials of recent years.
Heart failure treatment: The evolution of vasodilators Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, discusses the evolution of vasodilators used in heart failure treatment.

What's new in the management of chronic heart failure

Social Media